Research ArticleArticle
Detailed Analysis of the Articular Domain in Patients with Primary Sjögren Syndrome
Rada V. Moerman, Suzanne Arends, Petra M. Meiners, Arjan Vissink, Frederik K.L. Spijkervet, Frans G.M. Kroese, Elisabeth Brouwer and Hendrika Bootsma
The Journal of Rheumatology January 2017, jrheum.160459; DOI: https://doi.org/10.3899/jrheum.160459
Rada V. Moerman
From the Departments of Rheumatology and Clinical Immunology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands. The investigator-driven studies were financially supported by Roche, Woerden, the Netherlands, and Bristol Myers Squibb, Rueil Malmaison, France, which also supplied study medication. R.V. Moerman, MD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; P.M. Meiners, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; A. Vissink, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.K. Spijkervet, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.G. Kroese, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen. Address correspondence to Dr. H. Bootsma, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO-Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: h.bootsma@umcg.nl. Accepted for publication November 16, 2016.
Suzanne Arends
From the Departments of Rheumatology and Clinical Immunology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands. The investigator-driven studies were financially supported by Roche, Woerden, the Netherlands, and Bristol Myers Squibb, Rueil Malmaison, France, which also supplied study medication. R.V. Moerman, MD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; P.M. Meiners, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; A. Vissink, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.K. Spijkervet, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.G. Kroese, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen. Address correspondence to Dr. H. Bootsma, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO-Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: h.bootsma@umcg.nl. Accepted for publication November 16, 2016.
Petra M. Meiners
From the Departments of Rheumatology and Clinical Immunology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands. The investigator-driven studies were financially supported by Roche, Woerden, the Netherlands, and Bristol Myers Squibb, Rueil Malmaison, France, which also supplied study medication. R.V. Moerman, MD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; P.M. Meiners, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; A. Vissink, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.K. Spijkervet, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.G. Kroese, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen. Address correspondence to Dr. H. Bootsma, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO-Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: h.bootsma@umcg.nl. Accepted for publication November 16, 2016.
Arjan Vissink
From the Departments of Rheumatology and Clinical Immunology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands. The investigator-driven studies were financially supported by Roche, Woerden, the Netherlands, and Bristol Myers Squibb, Rueil Malmaison, France, which also supplied study medication. R.V. Moerman, MD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; P.M. Meiners, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; A. Vissink, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.K. Spijkervet, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.G. Kroese, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen. Address correspondence to Dr. H. Bootsma, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO-Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: h.bootsma@umcg.nl. Accepted for publication November 16, 2016.
Frederik K.L. Spijkervet
From the Departments of Rheumatology and Clinical Immunology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands. The investigator-driven studies were financially supported by Roche, Woerden, the Netherlands, and Bristol Myers Squibb, Rueil Malmaison, France, which also supplied study medication. R.V. Moerman, MD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; P.M. Meiners, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; A. Vissink, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.K. Spijkervet, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.G. Kroese, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen. Address correspondence to Dr. H. Bootsma, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO-Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: h.bootsma@umcg.nl. Accepted for publication November 16, 2016.
Frans G.M. Kroese
From the Departments of Rheumatology and Clinical Immunology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands. The investigator-driven studies were financially supported by Roche, Woerden, the Netherlands, and Bristol Myers Squibb, Rueil Malmaison, France, which also supplied study medication. R.V. Moerman, MD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; P.M. Meiners, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; A. Vissink, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.K. Spijkervet, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.G. Kroese, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen. Address correspondence to Dr. H. Bootsma, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO-Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: h.bootsma@umcg.nl. Accepted for publication November 16, 2016.
Elisabeth Brouwer
From the Departments of Rheumatology and Clinical Immunology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands. The investigator-driven studies were financially supported by Roche, Woerden, the Netherlands, and Bristol Myers Squibb, Rueil Malmaison, France, which also supplied study medication. R.V. Moerman, MD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; P.M. Meiners, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; A. Vissink, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.K. Spijkervet, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.G. Kroese, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen. Address correspondence to Dr. H. Bootsma, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO-Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: h.bootsma@umcg.nl. Accepted for publication November 16, 2016.
Hendrika Bootsma
From the Departments of Rheumatology and Clinical Immunology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands. The investigator-driven studies were financially supported by Roche, Woerden, the Netherlands, and Bristol Myers Squibb, Rueil Malmaison, France, which also supplied study medication. R.V. Moerman, MD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; S. Arends, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; P.M. Meiners, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; A. Vissink, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.K. Spijkervet, MD, PhD, Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen; F.G. Kroese, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen; H. Bootsma, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen. Address correspondence to Dr. H. Bootsma, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO-Box 30.001, 9700 RB Groningen, the Netherlands. E-mail: h.bootsma@umcg.nl. Accepted for publication November 16, 2016.
Data supplements
Data Supplement
Data Supplement
Files in this Data Supplement:
- Data Supplement - Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Detailed Analysis of the Articular Domain in Patients with Primary Sjögren Syndrome
Rada V. Moerman, Suzanne Arends, Petra M. Meiners, Arjan Vissink, Frederik K.L. Spijkervet, Frans G.M. Kroese, Elisabeth Brouwer, Hendrika Bootsma
The Journal of Rheumatology Jan 2017, jrheum.160459; DOI: 10.3899/jrheum.160459
Detailed Analysis of the Articular Domain in Patients with Primary Sjögren Syndrome
Rada V. Moerman, Suzanne Arends, Petra M. Meiners, Arjan Vissink, Frederik K.L. Spijkervet, Frans G.M. Kroese, Elisabeth Brouwer, Hendrika Bootsma
The Journal of Rheumatology Jan 2017, jrheum.160459; DOI: 10.3899/jrheum.160459